{"generic":"Sinecatechins","drugs":["Sinecatechins","Veregen"],"mono":{"0":{"id":"928804-s-0","title":"Generic Names","mono":"Sinecatechins"},"1":{"id":"928804-s-1","title":"Dosing and Indications","sub":{"0":{"id":"928804-s-1-4","title":"Adult Dosing","mono":"<b>Condyloma acuminatum, External:<\/b> apply a 0.5 cm strand of ointment topically 3 times daily to each external genital and perianal warts; continue treatment until complete clearance of warts, but no longer than 16 weeks "},"1":{"id":"928804-s-1-5","title":"Pediatric Dosing","mono":"safety and efficacy not established in pediatric patients; not recommended for treatment of urethral, intravaginal, cervical, rectal, or intra-anal human papilloma viral disease "},"3":{"id":"928804-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Condyloma acuminatum, External<br\/>"}}},"3":{"id":"928804-s-3","title":"Contraindications\/Warnings","sub":[{"id":"928804-s-3-9","title":"Contraindications","mono":"history of sensitivity reactions to any component of the product <br\/>"},{"id":"928804-s-3-10","title":"Precautions","mono":"<ul><li>avoid use on open wounds<\/li><li>may weaken condoms and vaginal diaphragms; use in combination not recommended<\/li><li>not recommended for treatment of urethral, intra-vaginal, cervical, rectal, or intra-anal human papilloma viral disease<\/li><\/ul>"},{"id":"928804-s-3-11","title":"Pregnancy Category","mono":"C (FDA)<br\/>"},{"id":"928804-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"928804-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Dermatologic:<\/b>Burning sensation (67%), Edema (45%), Erythema (70%), Induration of skin (35%), Pruritus (69%), Rash, Vesicular (20%), Superficial ulcer of skin (49%)<\/li><li><b>Other:<\/b>Pain (56%)<\/li><\/ul>"},"6":{"id":"928804-s-6","title":"Drug Name Info","sub":{"0":{"id":"928804-s-6-17","title":"US Trade Names","mono":"Veregen<br\/>"},"2":{"id":"928804-s-6-19","title":"Class","mono":"Keratolytic<br\/>"},"3":{"id":"928804-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"928804-s-6-21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"928804-s-7","title":"Mechanism Of Action","mono":"The exact mechanism of action against external genital or perianal warts is unknown. In vitro, sinecatechins have antioxidant activity; however, the clinical significance of this function in not known it is not known.<br\/>"},"9":{"id":"928804-s-9","title":"Administration","mono":"<b>Topical<\/b><br\/><ul><li>wash hand well before and after application<\/li><li>washing treated area prior to next application is not necessary<\/li><li>use fingers to apply ointment to each wart and ensure complete coverage; leave a thin lay or ointment on the warts<\/li><li>ointment may stain clothing or bedding<\/li><\/ul>"},"10":{"id":"928804-s-10","title":"Monitoring","mono":"<ul><li>clinical response on the number and area of involvement with genital and\/or perianal warts<\/li><li>signs of excessive or worsening application site reactions (local pain, erythema, vesicles, skin erosion\/ulceration, induration)<\/li><li>open sores, signs or symptoms of genital herpes simplex, and superinfection of warts and ulcers<\/li><\/ul>"},"11":{"id":"928804-s-11","title":"How Supplied","mono":"<b>Veregen<\/b><br\/>Topical Ointment: 15 %<br\/>"},"13":{"id":"928804-s-13","title":"Clinical Teaching","mono":"<ul><li>Warn patient that drug may weaken condoms or vaginal diaphragms. Recommend additional form of birth control. <\/li><li>Ointment may stain bedding or clothing.<\/li><li>Patient should report signs\/symptoms of excessive or worsening application site reactions (local pain, erythema, vesicles, skin erosion\/ulceration induration).<\/li><li>Instruct patient to avoid use on open wounds.<\/li><\/ul>"}}}